Five days on 5 mg can stop; six weeks still need a written step-down

Five days on 5 mg can stop; six weeks cannot

Five days on 5 mg can stop; six weeks cannot. A modest daily stack often ends without a step-down. Weeks at a supraphysiologic dose need a written taper so the HPA axis can wake. The 5 mg tablet is a unit, not a duration. The card marks that stop. It is not a pharmacy.

The active salt still needs a written stop date on the bottle

The active salt still needs a written stop date. Prednisolone does not need hepatic conversion from prednisone. That does not cancel axis suppression if the course runs long. Write the stop date on the bottle. A take-until-gone 5 mg script that lasts six weeks is a taper card, not a burst. Tablets are not for sale here.

5 mg x 30 quotes that are not prednisone

PMX prednisolone card quotes, August 2026. Walmart / Target / Publix / Harris Teeter. 5 mg x 30. Not prednisone. Snapshot. Script required. Not a cart.

Walmart, Target, Publix, and Harris Teeter already post coupon numbers for prednisolone 5 mg x 30 - not prednisone, not Millipred unless that NDC is on the script. Figures below are August 2026 snapshots from GoodRx and SingleCare. Your ZIP moves the dollar. Confirm the salt at the counter.

Burst length on a 5 mg tablet is the real prescription

Systemic glucocorticoids are among the oldest effective anti-inflammatory drugs we have, and prednisolone remains a workhorse because it is already active, well absorbed orally, and available as tablets, oral solution, and IV formulations worldwide.

Prednisone is a prodrug converted by 11β-hydroxysteroid dehydrogenase type 1 to prednisolone. In patients with severe hepatic dysfunction, prednisone conversion is unreliable-prednisolone is the molecule you want when you need the drug on board without betting on liver metabolism.

You will prescribe prednisolone for asthma exacerbations (especially peds), rheumatologic flares, allergic reactions, transplant immunosuppression (often as part of multi-drug regimens), and countless short 'burst' courses in primary care. The indication sets the dose and duration-not the other way around.

Anti-inflammatory potency is roughly four times hydrocortisone and equivalent to prednisone on a milligram basis once prednisone is converted. Mineralocorticoid activity is low at usual anti-inflammatory doses-fludrocortisone this is not.

Card note: every short course is not harmless: hyperglycemia in diabetics, mood lability, insomnia, and infection risk still appear. Long courses add osteoporosis, cataracts, adrenal suppression, and skin fragility. The patient who 'only takes steroids once a year' for COPD still needs counseling about glucose and infection.

Pediatric liquid formulations (Prelone, Orapred) use prednisolone sodium phosphate or prednisolone base-verify concentration (mg/mL) before dispensing or dosing. A parent measuring 'a teaspoon' without a syringe is a dosing error waiting to happen.

Every rheumatology flare, asthma exacerbation, and contact dermatitis burst you write adds to lifetime steroid exposure-document indication and planned duration in the chart so the next prescriber knows why it started.

Patients compare prednisone and prednisolone interchangeably in conversation; pharmacists may dispense one when the other was written in states where interchange is allowed-know your local rules and hepatic conversion issues.

Dexamethasone has longer duration and higher potency-do not swap 40 mg prednisolone for 40 mg dexamethasone without recalculating equivalence.

Prednisolone is active steroid now-peds red liquid for asthma, tablets for flares. Duration drives toxicity: five days versus five months; taper follows weeks at supraphysiologic dose, not mood.

Burst courses feel routine until the diabetic patient lands in DKA or the psychiatric patient decompensates-short does not mean safe for everyone. Screen comorbidity before the reflex prednisolone script.

Prednisolone differs from prednisone in one clinically decisive way: it is already the active glucocorticoid. Prednisone requires hepatic 11-beta-hydroxysteroid dehydrogenase type 1 conversion, which becomes unreliable in severe liver disease, acute hepatic failure, and some pediatric contexts where you want predictable steroid exposure. When enteral administration is feasible and you need oral steroid, prednisolone tablets or liquid deliver the effect without betting on conversion. Equipotency with prednisone on a milligram basis assumes normal activation-do not assume prednisone 40 mg equals prednisolone 40 mg in decompensated cirrhosis.

Duration at supraphysiologic dose drives HPA suppression risk more than any single milligram number, though higher doses suppress faster. Rough teaching: less than two weeks of burst therapy often needs no taper in many asthma pathways; beyond two to three weeks at supraphysiologic doses, gradual withdrawal over weeks protects against adrenal crisis. Patients who stop high-dose courses abruptly because they feel better day five may still crash if the course was longer than they remember-write explicit stop dates and taper instructions on the bottle, not only 'as directed.'

Rheumatology bridging courses often run weeks at 20-40 mg with slow tapers over months-patients need written calendars because 'taper prednisolone' on discharge without milligram schedule fails at the pharmacy window.

Asthma action plans should distinguish controller inhaled steroids from oral burst prednisolone-parents who confuse brown inhaler with red liquid over-treat or under-treat different problems.

Discharge summaries that say 'continue prednisolone' without milligrams or stop date are how patients run two-week courses for five-day exacerbations - write '40 mg daily through Thursday, then stop' in the sig and on the after-visit summary.

Active glucocorticoid, no 11-beta conversion step

Prednisolone diffuses across cell membranes and binds cytoplasmic glucocorticoid receptors (GR). The drug-receptor complex translocates to the nucleus, binds glucocorticoid response elements, and modulates gene transcription-upregulating anti-inflammatory proteins like lipocortin-1 (annexin-1) and downregulating pro-inflammatory cytokines, COX-2, and adhesion molecules.

Card note: non-genomic effects occur at high concentrations: membrane interactions and direct inhibition of ion channels contribute to rapid anti-inflammatory actions before full genomic reprogramming.

Net effect: suppressed leukocyte migration, reduced cytokine and prostaglandin production, stabilized lysosomal membranes, and decreased capillary permeability. That is why wheezing improves, joints quiet down, and rashes fade- and why infection surveillance matters because innate immunity takes a hit.

Mineralocorticoid receptor cross-activation appears at higher doses or in sensitive individuals, causing sodium retention and potassium loss-usually less prominent than with hydrocortisone but relevant in heart failure and hypertension.

HPA axis suppression follows exogenous glucocorticoid feedback at the hypothalamus and pituitary. Duration and dose determine recovery time-physiologic replacement is ~5-7 mg prednisolone equivalent daily; bursts of 40-60 mg suppress axis for weeks if continued long enough.

Topical, inhaled, and intra-articular steroids share receptor pharmacology but differ in systemic exposure-do not double-count inhaled fluticasone and oral prednisolone without acknowledging total steroid load.

Card note: glucocorticoid receptor antagonists like mifepristone exist for Cushing syndrome-far beyond routine prednisolone use but useful for mechanism completeness.

Morning dosing aligns with circadian cortisol rhythm and may reduce insomnia compared with evening bursts-though convenience drives adherence too.

Gene expression changes persist after plasma levels fall-biologic half-life exceeds pharmacokinetic half-life, which is why tapers are longer than five half-lives.

Card note: genomic effects take hours-'wired tonight, wheeze better tomorrow' sets burst expectations and reduces panic calls.

Inhaled and intranasal steroids contribute to total systemic exposure-add oral prednisolone burst when assessing HPA suppression and glucose effects.

Card note: mineralocorticoid receptor cross-activation at higher doses contributes to fluid retention-relevant in heart failure and hypertension comorbidity.

Salt, liquid strength, and why cirrhosis prefers this molecule

Oral prednisolone is well absorbed, with peak plasma concentrations in one to two hours. Bioavailability exceeds 80%-food may delay absorption slightly but is not clinically critical for most burst regimens.

Prednisolone binds transcortin (corticosteroid-binding globulin) and albumin. Only unbound drug is active; CBG levels rise with estrogen therapy, changing free fraction in pregnancy and on oral contraceptives.

Hepatic metabolism includes reduction, conjugation, and conversion to inactive metabolites. Unlike prednisone, you do not depend on 11β-HSD activation-prednisolone is already the active moiety.

Elimination half-life is two to four hours for the parent compound, but biologic half-life of glucocorticoid effect is longer-12-36 hours depending on dose and tissue effect- which is why alternate-day dosing schemes exist for chronic use.

Renal excretion of metabolites dominates; severe renal failure does not usually require dose change for short bursts but may prolong exposure-monitor edema and blood pressure.

IV prednisolone (where available) or methylprednisolone is used when oral route fails; do not assume mg-for-mg interchange across corticosteroids without checking relative potency tables.

Prednisolone is already active-hepatic encephalopathy or cirrhosis patients get more predictable effect than prednisone prodrug in many teaching scenarios.

Alternate-day dosing for chronic immunosuppression attempts to spare HPA axis-burst courses do not use that pattern.

Enteric-coated prednisone delays absorption-prednisolone immediate-release tablets and liquids peak faster for acute exacerbations.

Active drug in cirrhosis beats prednisone prodrug unpredictability-board and bedside point when enteral route still works.

Asthma bursts versus weeks that suppress the axis

Acute asthma exacerbations in children: short courses of oral prednisolone (1-2 mg/kg/day, max 40-60 mg, for 3-5 days) reduce relapse and hospitalization-evidence supports brief bursts without taper in many pediatric protocols when total duration stays under two weeks.

Adult asthma and COPD exacerbations often use prednisone or prednisolone 40 mg daily for five days in GINA/GOLD-aligned pathways-efficacy for accelerating recovery is robust; benefit must be weighed against hyperglycemia and insomnia.

Rheumatoid arthritis and lupus flares respond to moderate-to-high dose glucocorticoids as bridge therapy while DMARDs take effect-prednisolone is not disease-modifying; it buys time.

Allergic reactions and asthma from anaphylaxis adjunct: steroids prevent biphasic reactions in theory; epinephrine remains first-line for anaphylaxis-do not send someone home with only prednisolone from the ED without appropriate acute care.

Transplant and autoimmune maintenance use lower doses with meticulous monitoring-outside burst teaching but same drug, longer timeline, higher stakes for bone and infection.

Topical and inhaled routes outperform oral for localized disease when possible-oral prednisolone is systemic by design.

GINA and GOLD update short burst durations periodically-five-day courses for COPD exacerbation reduce total steroid exposure versus two-week traditions.

Contact dermatitis and poison ivy bursts at 0.5-1 mg/kg briefly remain common primary care patterns-counsel on insomnia and mood even for 'short' courses.

Card note: transplant protocols use prednisolone or methylprednisolone as part of induction-outside general burst teaching but same HPA concerns at low maintenance doses.

Peds asthma bursts need explicit stop dates and return precautions-not just mg/kg math. COPD five-day bursts cut exposure versus old two-week habits.

Allergic contact dermatitis and poison ivy: 0.5-1 mg/kg short bursts remain community practice; set stop date and warn about mood and glucose even for five to seven days.

Pediatric oral liquids-Prelone, Orapred, and generics-vary in concentration between 5 mg/5 mL and 15 mg/5 mL formulations. A parent drawing '5 mL' from the wrong bottle delivers a triple overdose or useless sub-therapeutic dose. Prescribe in milligrams, demonstrate milliliters with an oral syringe at bedside, and label the home bottle with mg dose and mL volume. Cherry flavor does not mean cough syrup-store separately from OTC cold medicines to prevent accidental double dosing.

Strongyloides hyperinfection before immunosuppression is a prednisolone safety story that belongs in every steroid lecture. Patients from or traveling through endemic regions (parts of Southeast Asia, Latin America, sub-Saharan Africa, and Appalachian United States pockets) may harbor asymptomatic Strongyloides stercoralis. Steroids without antiparasitic treatment can trigger autoinfection acceleration with mortality. Ask exposure history before bursts and before chronic immunosuppression; pair with ivermectin thinking when indicated-treat the parasite before the steroid when risk warrants.

Rheumatology bridging at 40 mg daily for six weeks then a vague 'taper' on discharge is how adrenal crises happen in March - give a calendar: 40 × 2 weeks, 30 × 1 week, 20 × 1 week, 10 × 1 week, then stop or hand off to rheumatology with explicit mg steps.

Type 2 diabetes on metformin plus glipizide needs a fingerstick plan day one of a 40 mg burst - hyperglycemia often peaks before wheeze improves, and patients blame the inhaler instead of the steroid if you did not warn them.

5 mg as a unit, not a duration

Card note: pediatric asthma exacerbation: prednisolone 1-2 mg/kg/day (max 40-60 mg) once daily or divided for 3-5 days. Use calibrated oral syringe with liquid formulation-teach parents the mg dose, not 'teaspoons.'

Adult asthma/COPD burst: 40 mg prednisolone daily × 5 days is common; some evidence supports 5 days non-inferior to longer in COPD.

Rheumatologic flares: highly variable-40-60 mg/day initially with slow taper over weeks to months under specialist care.

Physiologic replacement in adrenal insufficiency: ~5 mg prednisolone daily in divided doses-far below anti-inflammatory bursts.

Taper: if supraphysiologic dosing continues beyond roughly two to three weeks, assume HPA suppression and taper gradually (e.g., reduce by 5-10 mg prednisolone equivalent every 1-2 weeks depending on duration). Short pediatric bursts often need no taper per many protocols-know your local guideline.

Stress dosing: patients on chronic replacement who cannot take PO need parenteral hydrocortisone during illness or surgery-endocrine consult territory.

Write 'prednisolone 40 mg daily × 5 days, then stop' explicitly when no taper is intended-ambiguity causes patients to taper unnecessarily or stop day two.

Liquid pediatric dosing: calculate mg/kg then convert to mL using bottle concentration-never '5 mL' without mg.

If patient already on chronic low-dose prednisolone for adrenal insufficiency, stress-dose rules override burst math-do not stop their baseline.

15 mg/5 mL versus 5 mg/5 mL liquid triples error risk-label mg and mL; bedside teach-back with syringe.

Alternate-day prednisolone for chronic immunosuppression attempts HPA sparing; burst courses use daily dosing without alternate-day pattern-do not mix paradigms.

When converting from IV methylprednisolone to oral prednisolone in hospitalized asthma, approximate equipotency then write a clear home prednisolone burst with stop date-do not discharge on 'continue steroids' without milligrams or duration.

Rheumatology tapers over months use smaller decrements as dose approaches physiologic replacement-5 mg steps above 20 mg, 2.5 mg steps below 10 mg is a common outpatient pattern under specialist supervision.

Adrenal insufficiency patients carry emergency hydrocortisone injection kits-prednisolone burst for unrelated indication does not replace their maintenance; reconcile both plans explicitly.

Obesity in pediatric asthma: use actual body weight for mg/kg calculations per local protocol-ideal versus actual weight decisions affect dose and should follow institutional guideline.

Card note: transplant recipients on prednisolone maintenance need coordinated taper only through transplant team-primary care bursts for COPD atop low-dose maintenance require specialist awareness of total steroid load.

Hospitalized elders started on prednisolone for COPD without clear indication are a delirium vector - confirm the burst is guideline-concordant before the night nurse gives the first dose.

Psychiatric history: mania on day three at 40 mg is not rare enough to skip the warning - give patients and partners a call-before-stopping number when mood lability exceeds insomnia.

NSAIDs, live vaccines, and the Strongyloides pairing

CYP3A4 inducers (rifampin, phenytoin, carbamazepine) accelerate corticosteroid metabolism-may need higher doses or switch steroid.

CYP3A4 inhibitors (ketoconazole, ritonavir) increase exposure-watch Cushingoid features and glucose.

NSAIDs plus glucocorticoids raise GI ulceration risk-consider PPI in high-risk patients on combined therapy.

Anticoagulants: unpredictable effects on warfarin; monitor INR when starting or stopping steroids.

Vaccines: live vaccines contraindicated during significant immunosuppression; inactivated vaccines may have reduced response-time immunizations before planned long courses when possible.

Card note: diabetes medications: insulin and oral agents need adjustment-check glucose daily early in burst therapy.

Card note: strongyloides hyperinfection risk rises when prednisolone starts before antiparasitic treatment-see ivermectin monograph for endemic exposure screening.

Live vaccines wait until immunosuppression resolves-plan shingles and flu vaccines before long courses when schedule allows.

Potassium and sodium shifts matter in heart failure-monitor edema and electrolytes on combined diuretic and steroid bursts.

Rifampin and phenytoin induce steroid clearance-transplant/neuro patients need specialist dose math, not guesswork.

Concurrent PPI may reduce GI bleeding risk with NSAID plus prednisolone combinations in high-risk elders-balance against PPI long-term effects when steroid course is only five days.

Thiazolidinediones and prednisolone both affect glucose-diabetics on pioglitazone need tighter monitoring during bursts.

Cyclosporine and prednisolone co-therapy in transplant is standard but raises infection and glucose burden-outside burst teaching yet same drug interaction literacy applies when transplant patient gets primary care COPD burst.

Herbal supplements claiming 'adrenal support' do not replace taper schedules-counsel against substituting unproven products when HPA suppression is suspected after prolonged courses.

Same patient, third COPD burst this year - note cumulative steroid exposure in the problem list and discuss inhaled optimization before the fourth script.

Preoperative patients on chronic prednisolone need stress-dose hydrocortisone per endocrine - do not confuse that protocol with a five-day asthma burst stop date.

Mood, glucose, bone - and HPA sleep after long courses

Short course: insomnia, mood changes (euphoria or depression), appetite increase, hyperglycemia, fluid retention, acne flare.

Long course: osteoporosis, avascular necrosis, cataracts, glaucoma, striae, myopathy, Cushingoid habitus, infection (including reactivation of TB and strongyloides-see ivermectin monograph for parasite context before starting steroids in endemic exposure).

Adrenal crisis if chronic therapy stopped abruptly-teach stress dosing for patients on replacement.

Psychiatric: mania, psychosis, and suicidal ideation reported-psychiatric history lowers threshold for inpatient monitoring on high doses.

Pediatric growth suppression with chronic use-use lowest effective dose and alternate-day schedules when long therapy unavoidable.

Peptic ulcer disease risk increases with NSAID co-use and in ICU stress-dose regimens.

Avascular necrosis presents months after courses-hip pain in young adults on repeated bursts warrants MRI.

Mood disturbance can destabilize bipolar patients at modest doses-psychiatric history lowers threshold for inpatient monitoring.

Card note: skin thinning and bruising accumulate with repeat bursts-document cumulative exposure when same patient returns quarterly.

Diabetics: hyperglycemia day two-fingersticks or CGM plan before discharge with steroid alone.

Repeated bursts in same year accumulate osteoporosis and cataract risk-track cumulative exposure in problem list for patients with frequent COPD or asthma exacerbations.

Card note: five-day prednisolone bursts still cause insomnia and hyperglycemia in vulnerable patients-'short course' is not 'no side effects.' Parents report behavioral changes in children within forty-eight hours; diabetics need glucose plans day one.

Osteonecrosis of hip or knee may present months after a seemingly trivial burst-ask about joint pain in patients with repeated steroid exposure when evaluating new limp or groin pain.

Ophthalmology referral for cataract and glaucoma screening follows chronic use patterns; even multiple bursts per year warrant baseline eye history documentation.

Night sweats and mood swings on day four of a burst in a patient with bipolar history - lower the threshold for same-day psychiatry contact; steroids unmask mania faster than many prescribers expect.

Frail elders on prednisolone for COPD may decompensate from insomnia alone - consider morning dosing and short course confirmation before the hospitalist reflexes to 14 days.

Kids liquids, pregnancy, and hepatic conversion gaps

Card note: pregnancy: corticosteroids cross placenta; use lowest effective dose for maternal indication-prednisolone is preferred over dexamethasone when less fetal exposure is desired in some guidelines because of placental metabolism differences.

Lactation: low transfer; generally compatible with short courses.

Pediatrics: weight-based dosing mandatory; Prelone/Orapred liquids require concentration check-common strengths 5 mg/5 mL and 15 mg/5 mL exist.

Card note: geriatrics: higher osteoporosis, glucose, and delirium risk-shortest effective burst; fall precautions if insomnia and steroid psychosis appear.

Hepatic impairment: advantage over prednisone because no activation step-still monitor fluid and glucose.

Diabetes: plan glucose monitoring and medication adjustment before day one of therapy.

Card note: prelone 15 mg/5 mL versus 5 mg/5 mL bottles look similar-pharmacist verification and parent teach-back prevent three-fold overdose.

Breastfeeding short courses generally acceptable; high-dose prolonged use needs lactation consult.

Growth charts in children on repeated bursts-refer to pediatric endocrinology if frequent oral steroids needed.

Card note: strongyloides before steroids in endemic exposure-pair with ivermectin thinking whenever immunosuppression starts in at-risk travel or residence history.

Write the stop date before the bottle leaves

Take with food or milk if stomach upset-morning dosing reduces insomnia for some patients.

Finish the burst unless severe side effects-explain that stopping day two may mean incomplete treatment of the exacerbation.

If on therapy more than two weeks, do not stop suddenly-ask how to taper before discharge.

Card note: report fever, productive cough, or exposure to chickenpox/shingles while immunosuppressed.

Diabetics: check glucose more often the first week.

Parents: demonstrate oral syringe dosing in mg; write the volume on the bottle label to match your prescription.

Adrenal insufficiency card for patients on chronic replacement-stress steroids during illness.

Card note: if mood swings or insomnia unbearable, call before stopping abruptly when course was meant to be two weeks.

Bone health: calcium and vitamin D for anyone anticipating repeat courses beyond twice yearly.

Written stop date: 'Last pill Wednesday.' Ambiguous 'short course' yields three-day stop or month-long continuation.

Pediatric parents confuse Prelone with cherry cough syrup-store separately, label with child's name and mg dose, use oral syringe only.

Card note: adverse effects scale with duration and dose but do not spare short bursts entirely. Hyperglycemia in diabetics, insomnia, mood lability, and infection susceptibility appear within days. Geriatric delirium on prednisolone bursts is underrecognized-avoid casual steroid scripts in hospitalized elders without indication. Bone health counseling for anyone anticipating more than two bursts per year includes calcium, vitamin D, and weight-bearing activity; refer for DEXA when cumulative exposure grows.

Chickenpox exposure while on burst prednisolone needs same-day infectious disease input - varicella in an immunosuppressed adult is not a watch-and-wait rash.

Same patient, third COPD burst this year - document cumulative exposure and push inhaled optimization before the fourth oral course.

Morning prednisolone with breakfast reduces some insomnia complaints versus evening dosing - trade-off against circadian mimicry is minor for five-day bursts.

Five days can stop cold; weeks need a written taper

Card note: prednisolone is the active glucocorticoid-use it when you want reliable oral steroid effect without prednisone conversion, especially in liver disease and pediatric liquid dosing.

Match dose and duration to indication; many asthma bursts need no taper, but courses beyond two to three weeks at supraphysiologic doses require gradual withdrawal and HPA axis consideration.

Card note: monitor glucose, mood, infection, and bone health proportional to duration. Teach syringe dosing for peds liquids and stress-dose rules for chronic replacement patients.

Active glucocorticoid status means prednisolone-not prednisone-is your friend in liver disease and when you need liquid pediatric dosing you can trust.

Pair steroid starts with parasite and infection thinking when travel history or endemic exposure fits strongyloides risk.

Active glucocorticoid, duration-based taper, syringe peds dosing, parasite screen before steroids when history fits-four rules on one index card.

Prednisolone bottom line: active steroid without prednisone conversion; burst duration drives taper need; peds liquid requires mg-to-mL verification; strongyloides before steroids when endemic exposure-pair with ivermectin Analysis of same patients.

Write stop dates on the bottle - ambiguity causes more harm than a slightly long burst.

Inhaled fluticasone plus oral burst counts toward total glucocorticoid load when you wonder why glucose spiked on 'only five days.'

Poison ivy burst at 0.5 mg/kg for five days still causes insomnia - set expectations before the patient returns angry on day two.

Rheumatology handoff: if you start 40 mg and refer, include today's date and planned taper steps so the specialist does not restart at 60 mg unaware of your week already completed.

Pediatric behavioral changes on day two of a burst are common enough that school nurses should know - a call home beats an unnecessary psychiatry referral when the course ends in four days.